Medindia LOGIN REGISTER
Medindia
Advertisement

Sunesis Pharmaceuticals to Present at Healthcare Investor Conferences in March

Friday, March 14, 2008 General News
Advertisement
SOUTH SAN FRANCISCO, Calif., March 13 SunesisPharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Daniel Swisher,Sunesis' Chief Executive Officer and President, will provide a corporateoverview at two upcoming investor conferences in March.
Advertisement

Interested parties may access a webcast of each the presentations byvisiting the Sunesis website at http://ir.sunesis.com. A replay of thewebcasts will be archived on the "Calendar of Events" page in the Investorsand Media section of the Sunesis website for two weeks.
Advertisement

About Sunesis Pharmaceuticals

Sunesis is a clinical-stage biopharmaceutical company focused on thediscovery, development and commercialization of novel small-moleculetherapeutics for oncology and other serious diseases. Sunesis has built abroad product candidate portfolio through internal discovery and in-licensingof novel cancer therapeutics. Sunesis is advancing its product candidatesthrough in-house research and development efforts and strategic collaborationswith leading pharmaceutical and biopharmaceutical companies. For furtherinformation on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.-- Mr. Swisher will speak at the Cowen and Company 28th Annual Health Care Conference at 8:45 a.m. Eastern Time on Tuesday, March 18, 2008 at the Boston Marriott Copley Place in Boston, Mass. -- On Thursday, March 20, 2008, Mr. Swisher will present at the Lehman Brothers Eleventh Annual Global Healthcare Conference at 12:45 p.m. Eastern Time in Miami, Fla.

SOURCE Sunesis Pharmaceuticals, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close